The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
TACE with or without lenvatinib as adjuvant therapy for HCC with microvascular invasion (MVI) or portal vein thrombus (Cheng’s I/II): A single-center, prospective, non-randomized cohort study.
 
Chengpei Zhu
No Relationships to Disclose
 
Feng Wu
No Relationships to Disclose
 
Zibo Xu
No Relationships to Disclose
 
Chengjie Li
No Relationships to Disclose
 
Liang Di
No Relationships to Disclose
 
Xiaofei Zhao
No Relationships to Disclose
 
Yang Tan
No Relationships to Disclose
 
Shanshan Wang
No Relationships to Disclose
 
Kai Liu
No Relationships to Disclose
 
Haitao Zhao
No Relationships to Disclose
 
Daobing Zeng
No Relationships to Disclose
 
Guangming Li
No Relationships to Disclose